$FOXO Technologies(FOXO.US$
FOXO Technologies (AMEX:FOXO) shares increased by 102.9% to $0.27 during Monday's pre-market session. The market value of their outstanding shares is at $13.3 million.
FOXO Technologies (AMEX:FOXO) shares increased by 102.9% to $0.27 during Monday's pre-market session. The market value of their outstanding shares is at $13.3 million.
$Tivic Health Systems(TIVC.US$ buying the dip
1
$Beneficient(BENF.US$
Beneficient Entered Into $250M Standby Equity Purchase Agreement With YA II PN; Pursuant To SEPA
Beneficient Entered Into $250M Standby Equity Purchase Agreement With YA II PN; Pursuant To SEPA
$Minerva Neurosciences(NERV.US$
just wait for another wave of high $10.40
just wait for another wave of high $10.40
2
4
$GEN Restaurant Group(GENK.US$
Read: Cava Group CFO is confident restaurant chain will be profitable -- but she won't say when
The IPO market is closing out the second quarter with more momentum than it had in the beginning, as six IPOs are currently on the schedule for the last week of June, and four of those are expected to rake in upwards of $100 million.
Read: Cava Group CFO is confident restaurant chain will be profitable -- but she won't say when
The IPO market is closing out the second quarter with more momentum than it had in the beginning, as six IPOs are currently on the schedule for the last week of June, and four of those are expected to rake in upwards of $100 million.
1
$Minerva Neurosciences(NERV.US$
(NASDAQ:NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via private placement of its shares, priced at a premium to the current levels.
Minerva has agreed to sell an aggregate of 1.43 million shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares at a purchase price of $9.99 per pre-funded warrant.
(NASDAQ:NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via private placement of its shares, priced at a premium to the current levels.
Minerva has agreed to sell an aggregate of 1.43 million shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares at a purchase price of $9.99 per pre-funded warrant.
2